Book Closure

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE7368.45-286.35 (-3.74 %)
PREV CLOSE ( ) 7654.80
OPEN PRICE ( ) 7748.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2042
TODAY'S LOW / HIGH ( )7206.10 7748.65
52 WK LOW / HIGH ( )1947 7794
NSE7368.70-287.65 (-3.76 %)
PREV CLOSE( ) 7656.35
OPEN PRICE ( ) 7590.05
BID PRICE (QTY) 7368.70 (3)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 37535
TODAY'S LOW / HIGH( ) 7202.35 7600.00
52 WK LOW / HIGH ( )1950 7790

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.